A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer

BACKGROUND: Breast cancer is the most prevalent malignancy worldwide and the leading culprit for women’s death. Cuproptosis is a novel and promising modality of tumor cell death and the relationship with long non-coding RNAs (lncRNAs) remains shrouded in a veil. Studies in cuproptosis-related lncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hao, Liu, Yanbiao, Zhang, Wenrong, Peng, Ziqi, Yu, Xinmiao, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331703/
https://www.ncbi.nlm.nih.gov/pubmed/37434691
http://dx.doi.org/10.21037/tcr-22-2702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331703/
https://www.ncbi.nlm.nih.gov/pubmed/37434691
http://dx.doi.org/10.21037/tcr-22-2702

Ejemplares similares